Search
Satralizumab
go.drugbank.com/drugs/DB15762ApprovedInvestigationalan IgG2 framework. … occurs in a pH-dependent manner[A218551] - this allows satralizumab to bind an IL-6 receptor until it reaches an endosome, after which the drug may dissociate from the receptor and move back into the
Rozanolixizumab
go.drugbank.com/drugs/DB14919ApprovedInvestigationalRozonolixizumab itself is an IgG4P, an inactive isotype, to reduce the likelihood of unwanted chain exchange. … [A260192] As a result, the main clinical manifestation of myasthenia gravis is easily fatigable or persistent muscle weakness.
Chlorophetanol
go.drugbank.com/drugs/DB11368ExperimentalChlorophetanol is an agent known to have antifungal activities.
Ferric oxyhydroxide
go.drugbank.com/drugs/DB14695ExperimentalAn antiferromagnetic material; constitutes the core of natural ferritin.
IK-930
go.drugbank.com/drugs/DB18149InvestigationalIK-930 is an oral, paralog-selective TEAD inhibitor.
Naltalimide
go.drugbank.com/drugs/DB21082ExperimentalNaltalimide is a small molecule drug. Naltalimide has a monoisotopic molecular weight of 472.2 Da.
Fadaltran
go.drugbank.com/drugs/DB21100ExperimentalFadaltran is a small molecule drug. Fadaltran has a monoisotopic molecular weight of 419.23 Da.
Romurtide
go.drugbank.com/drugs/DB21196ExperimentalRomurtide is a small molecule drug. Romurtide has a monoisotopic molecular weight of 886.56 Da.
Nacartocin
go.drugbank.com/drugs/DB21214ExperimentalNacartocin is a small molecule drug. Nacartocin has a monoisotopic molecular weight of 985.51 Da.
Hibenzate
go.drugbank.com/drugs/DB21247ExperimentalHibenzate is a small molecule drug. Hibenzate has a monoisotopic molecular weight of 242.06 Da.